期刊文献+

高危高龄前列腺增生症经尿道电切手术的治疗体会 被引量:7

原文传递
导出
摘要 目的探讨高危高龄良性前列腺增生症(BPH)安全、有效的治疗方法。方法回顾性分析132例高危高龄BPH患者的临床资料。结果经充分的术前准备,132例高危高龄BPH患者均接受了经尿道前列腺电切术,手术时间30~90min,平均55min,切除组织质量20~80g,平均30g,术后排尿困难症状均明显改善,均获治愈出院。术中术后无电切综合征(TURS)发生,无手术死亡病例,1例因术后出血再手术治愈。结论加强围手术期处理,应用经尿道前列腺电切治疗高危高龄重度BPH具有安全、效果好、并发症少等优点。
出处 《中国临床研究》 CAS 2010年第1期48-49,共2页 Chinese Journal of Clinical Research
  • 相关文献

参考文献6

二级参考文献22

  • 1洪宝发,蔡伟,符伟军,杨勇,王威,陈耀富,展洁,张翠娥,李炎唐,崔胜堂.选择性绿激光汽化术治疗良性前列腺增生的临床研究[J].中华泌尿外科杂志,2005,26(1):17-19. 被引量:90
  • 2李义,叶敏,王加强,王孟春,王伟明.经尿道前列腺汽化电切术后尿道狭窄的防治[J].中华泌尿外科杂志,2005,26(2):121-124. 被引量:132
  • 3秦学斌,张文斌,蒋奕红,林高翔.速尿和3%高渗盐水在预防经尿道电切综合征(TUPPS)的探讨[J].中国现代医学杂志,2006,16(10):1529-1530. 被引量:5
  • 4李传刚,潘柏年.经尿道前列腺电切术并发症的防治[J].临床泌尿外科杂志,2006,21(6):477-480. 被引量:80
  • 5Uchida T,Ohori M,Soh S,et al.Factors influencing morbidity in patients undergoing transurethral resection of the prostate.Urology,1999 ,53:98-105.
  • 6Anson K.Could the latest generation potassium titanyl phosphate lasers be the ones to make transurethral resection of the prostate an operation of historical interest only? Curr Opin Urol,2004,14:27-29.
  • 7Shingleton WB,Terrell F,Renfroe L,et al.Low-power vs high-power KTP laser:improved method of laser ablation of prostate.J Endourol,1999,13:49-52.
  • 8Hai MA,Malek RS.Photoselective vaporization of the prostate :initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia.J Endourol,2003 ,17 :93-96.
  • 9Reich O,Bachmann A,Schneede P,et al.Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate.J Urol,2004,171 (6 Pt1) :2502-2504.
  • 10Malek RS,Kuntzman RS,Barrett DM.High power potassium-titanyl-phosphate laser vaporization prostatectomy.J Urol,2000,163:1730-1733.

共引文献466

同被引文献50

  • 1薛书成,武艺,裴昌松,李克,王玉林.经尿道等离子体双极电切术治疗前列腺增生[J].实用医技杂志,2008,15(33):4822-4824. 被引量:1
  • 2郭晋宁,朴仁京,陈博军,王漩.经尿道前列腺电汽化联合电切术选择性治疗前列腺增生32例[J].现代医药卫生,2006,22(8):1160-1160. 被引量:1
  • 3吴阶平 主编.泌尿外科学[M].济南:山东科技出版社,1996.286.
  • 4Descazeaud A, Azzousi AR, Ballereau C, et al. Impact of oral antico- agulation on morbidily of transurethral resec-tion of the prostate [J]. World J Urol, 2010, 10(2): 1007-1012.
  • 5Chen H, Tsai YS, Tong YC. Correlations among cardiovascular risk factors, prostate blood flow, and prostate volume in patients with clinical benign prostatic hyperplasia [J]. Urology, 2012, 79(2): 409-414.
  • 6Seung HL, Byung HC, Chung SK, et al. Survey on benign prostatic hyperplasia distribution and treatment patterns for men with lower urinary tract symptoms visiting urologists at general hospitals in Ko- rea: a prospective, noncontrolled, observational cohort study [J]. Urology, 2012, 79(6): 1379-1384.
  • 7Lei L, Liang W, Min F, et al. Two-year outcome of high-risk benign prostate hyperplasia patients treated with transurethral prostate re- section by plasmakinetic or conventional procedure [J]. Urology, 2012, 80(2): 389-395.
  • 8Steven AK. Clinical outcomes after combined therapy with dutaste- ride plus tamsulosin or either monotherapy in men with benign pros- tatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind combination of Avodart and Tam- sulosin (CombAT) Trial [J]. The Journal of Urology, 2012, 187(2): 583-584.
  • 9仲伟一,韩洪海,张悦,等.高龄高危前列腺增生症经尿道电切术治疗体会[J].中外健康文摘,2011,8(5):25-26.
  • 10童滨,陆卓君.高龄高危前列腺增生经尿道电汽化联合电切的临床探讨[J].中国内镜杂志,2008,14(1):88-90. 被引量:18

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部